Precipio

NEW HAVEN, Conn., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2023 corporate update call on August 17th at 5:00 PM ET. The call will include updates on all…

NEW HAVEN, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- Specialty…

NEW HAVEN, Conn., April 27, 2023 (GLOBE NEWSWIRE) -- Specialty…

NEW HAVEN, Conn., April 19, 2023 (GLOBE NEWSWIRE) -- Specialty…

NEW HAVEN, Conn., March 28, 2023 (GLOBE NEWSWIRE) -- Specialty…

<!-- Name:DistributionId Value:8783514 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4530 -->…

NEW HAVEN, Conn., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced another 4-year agreement with a new customer to bring HemeScreen™ technology into their laboratory. Based…